GMAB Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: The Motley Fool

Genmab (GMAB) Q3 2025 Earnings Call Transcript

17 days ago - By: Bloomberg

Genmab Wraps Up Leveraged Finance’s Biggest M&A Deal Since April

17 days ago - By: Benzinga

Major Victory For Genmab As Epkinly Receives FDA Approval For Type Of Pretreated Blood Cancer

17 days ago - By: Genmab A/S

Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma

2 months ago - By: Benzinga

Why Is Genmab Stock Trading Lower On Monday?

2 months ago - By: Zacks Investment Research - Mentions: AEG GFI SCSC DORM

New Strong Buy Stocks for October 3rd

24 days ago - By: Investor's Business Daily - Mentions: HALO

Halozyme Stock Surging On Recent Earnings Beat; Record High Ahead?

a month ago - By: Genmab A/S

Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting

a month ago - By: Zacks Investment Research - Mentions: JNJ ABBV

AbbVie Q3 Earnings & Sales Beat, 2025 EPS Outlook Raised

2 months ago - By: Genmab

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer

2 months ago - By: Brodsky & Smith LLC - Mentions: EA MRUS BRY CRC ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Electronic Arts Inc. (Nasdaq - EA), Merus N.V. (Nasdaq – MRUS), Berry Corporation (Nasdaq - BRY), Semler Scientific, Inc. (Nasdaq – SMLR)

2 months ago - By: The Motley Fool

Why Genmab Stock Popped on Friday

2 months ago - By: Brodsky & Smith LLC - Mentions: EA MRUS BRY SMLR ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Electronic Arts Inc. (Nasdaq – EA), Merus N.V. (Nasdaq – MRUS), Berry Corporation (Nasdaq – BRY), Semler Scientific, Inc. (Nasdaq – SMLR)

2 months ago - By: Investor's Business Daily - Mentions: PFE AAPL MRUS

Genmab Strikes $8 Billion Deal To Acquire Cancer-Focused Merus

2 months ago - By: Genmab A/S - Mentions: MRUS

Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model

3 months ago - By: Genmab A/S

Genmab Announces Updated Results from Phase 2 EPCORE® NHL-6 Study Evaluating Epcoritamab Monotherapy in the Outpatient Setting in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

3 months ago - By: Yahoo Finance - Mentions: ABBV JNJ

Genmab A/S (GMAB)’s Epcoritamab Delivers 95% Response in Lymphoma

3 months ago - By: Yahoo Finance - Mentions: PFE ABBV

Genmab A/S (GMAB) Expands Tivdak and Epkinly Commercial Push Globally

3 months ago - By: Yahoo Finance - Mentions: ACAD

ACADIA Pharmaceuticals Inc. (ACAD) Nears Phase 3 Readout in Prader-Willi Syndrome Trial

3 months ago - By: Genmab A/S

Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer (EC)

4 months ago - By: Yahoo Finance

William Blair Remains Bullish on Genmab A/S (GMAB)

4 months ago - By: Zacks Investment Research - Mentions: CRMD IOVA IMCR

IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi

4 months ago - By: Zacks Investment Research

Wall Street Analysts Believe Genmab (GMAB) Could Rally 33.8%: Here's is How to Trade

4 months ago - By: Genmab

Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL)

4 months ago - By: Zacks Investment Research - Mentions: PRGO CRMD IMCR

Perrigo Beats on Q2 Earnings & Sales, Stock Down on '25 Sales View Cut

4 months ago - By: Zacks Investment Research - Mentions: JAZZ CRMD IMCR

JAZZ Stock Down on Wider-Than-Expected Q2 Loss, '25 Sales View Cut

4 months ago - By: Zacks Investment Research - Mentions: SIRI VRTX CRSP IMCR

CRSP Stock Down on Huge Q2 Loss, Focus on Increasing Casgevy Adoption

4 months ago - By: Zacks Investment Research - Mentions: SNY BMRN IMCR

BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View

4 months ago - By: Zacks Investment Research - Mentions: SRPT ACAD

GENMAB A/S -SP ADR (GMAB) Stock News